Pharmaceutical Executive November 19, 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
The AI rush is on in pharma organizations. A recent report by McKinsey & Company estimates up to $110 billion annual potential1 across 21 pharma use cases in R&D, clinical development, operations, commercial, and medical affairs. But how do executives feel about where AI is taking us, when results will arrive, and how organizations will get there?
New data2 from a September 2024 report by our company show that an impressive 91% of life science executives say they believe in AI’s value (Figure 1), with only 7% reporting skepticism.
What’s more, pharma leaders are putting their beliefs into action. Three out of four respondents were either...
Today's Sponsors
Today's Sponsor